Improve the care and outcomes of your patients by participating in this dynamic course focused on the best practices and latest advances in interventional cardiology. The program features real-world clinical case presentations, audience participation, and focused discussion with world-renowned experts.
Return to your practice armed with the latest evidence-based research and practical information to improve patient outcomes.
By the end of the conference, participants should be able to:
- Utilize the results of important clinical trials and evidence-based medicine to guide the management of patients with atherosclerosis and structural heart disease
- Incorporate new interventional technologies and procedures into the care of patients with complex coronary and endovascular disease
- Apply advances in diagnostic evaluation and therapeutics to the treatment of patients with carotid and peripheral arterial disease
- Implement appropriate pharmacologic management in the care of patients undergoing diagnostic arteriography and interventional therapies before, during, and after catheterization
CME Accreditation and Designation
The Cardiovascular Research Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Cardiovascular Research Foundation designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Documentation of awarded credit is provided for registered attendees in exchange for completed activity evaluations. Certificates of attendance are provided to all registered attendees.
This program is designed for interventional cardiologists, endovascular specialists, clinical cardiologists, catheterization laboratory nurses, cardiovascular technologists, and other healthcare professionals involved in the performance of cardiovascular interventional procedures.
It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations and therefore, does not compromise the scientific integrity of the educational activity.
Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage are not endorsed by the Cardiovascular Research Foundation or the conference directors of this activity.
Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.
This activity is sponsored by the Cardiovascular Research Foundation and partially funded through educational grants from multiple commercial supporters.
Evaluation will address content, presentation, possible bias, and future educational needs.